Atrium Therapeutics, Inc. RNA
Set alert
8.27 USD +0.01 +0.12%
At close · Oct 30
8.27 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
7.88 Day range 8.31
7.61 52-week range 16.54
- YTD
- -43.93%
- 1 year
- -43.93%
- Open
- 8.19
- Prev close
- 8.26
- Mkt cap
- 141.46M
- Vol
- 566.64K
- Avg vol
- 272.10K
- EPS
- -5.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.88
- High
- 8.31
- Forward P/E
- -3.67
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.25%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 15.47
- 200-d avg
- 15.47
- 1y target
- 0.00
Financial health
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -3.3×
FY 2025 5y median -3.3× FY 2025
P/S 13.6×
FY 2025 5y median 13.6× FY 2025
P/B 1.2×
FY 2025 5y median 1.2× FY 2025
P/FCF -5.9×
FY 2025 5y median -5.9× FY 2025
EV/EBITDA 0.2×
FY 2025 5y median 0.2× FY 2025
EV/Sales -0.7×
FY 2025 5y median -0.7× FY 2025
FCF Yield -16.9%
FY 2025 5y median -16.9% FY 2025
Profitability
Gross Margin 100.0%
FY 2025 5y median 100.0% FY 2025
Operating Margin -412.6%
FY 2025 5y median -412.6% FY 2025
Net Margin -411.9%
FY 2025 5y median -411.9% FY 2025
ROE -37.0%
FY 2025 5y median -37.0% FY 2025
ROIC -31.9%
FY 2025 5y median -31.9% FY 2025
ROA -27.5%
FY 2025 5y median -27.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 6.5×
FY 2025 5y median 6.5× FY 2025
Quick Ratio 6.5×
FY 2025 5y median 6.5× FY 2025
Debt / Equity 0.0×
FY 2025 5y median 0.0× FY 2025
Net Debt / EBITDA 3.5×
FY 2025 5y median 3.5× FY 2025
Interest Coverage 0.0×
FY 2025 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31